BioNTech SE ADR buy Traumtanz
Start price
17.09.22
/
70%
€146.65
Target price
17.09.23
€150.00
Performance (%)
5.39%
End price
04.11.22
€154.55
Summary
This prediction ended on 04.11.22 with a price of €154.55. With a performance of 5.39%, the BUY prediction by Traumtanz for BioNTech SE ADR closed with a slight gain. Traumtanz has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% |
iShares Core DAX® | 1.743% | 1.903% | 18.038% |
iShares Nasdaq 100 | -2.088% | -0.640% | 25.594% |
iShares Nikkei 225® | 1.306% | 4.161% | 16.556% |
iShares S&P 500 | -0.093% | 0.169% | 24.312% |
According to Traumtanz what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
Very high dividend yield expected
Top Rating
Standard Investments for future growth
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Leading role in innovation
Some uniques
Very differentiated customer and product portfolio
Growths faster than the competition
Small Risks for its business
Market Leader or Top 3
Small cyclical dependencies
Future proof or reliable business model
Very positive Cash Flow expected
Stable Large shareholder and/or long term investor
Well known brand
Sustainability is very important
Cons
Comments by Traumtanz for this prediction
In the thread Biontech SE diskutieren
Buy mit Kursziel 150,0
In the thread Trading Biontech SE
Buy beendet
Stopped prediction by Traumtanz for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€93.90
18.12.23
18.12.23
€95.00
18.12.24
18.12.24
2.19%
28.12.23
28.12.23
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€97.18
15.05.23
15.05.23
€100.00
15.05.24
15.05.24
1.34%
01.06.23
01.06.23
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€143.15
26.12.22
26.12.22
-
01.03.24
01.03.24
-32.11%
15.05.23
15.05.23
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€165.75
13.12.22
13.12.22
€170.00
13.12.23
13.12.23
5.61%
15.12.22
15.12.22
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€155.10
04.11.22
04.11.22
€160.00
04.11.23
04.11.23
3.51%
09.12.22
09.12.22
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€162.65
30.03.22
30.03.22
€180.00
30.03.23
30.03.23
6.06%
04.08.22
04.08.22
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€88.51
21.12.20
21.12.20
€80.00
-2.06%
21.12.20
21.12.20
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€84.99
18.12.20
18.12.20
€80.00
4.14%
21.12.20
21.12.20
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€87.01
18.12.20
18.12.20
€80.00
-2.32%
18.12.20
18.12.20
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€85.50
17.12.20
17.12.20
€80.00
1.77%
18.12.20
18.12.20
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€107.02
11.12.20
11.12.20
€110.00
-20.11%
17.12.20
17.12.20
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€103.62
07.12.20
07.12.20
€105.00
3.28%
11.12.20
11.12.20
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€100.02
05.12.20
05.12.20
€102.00
3.60%
07.12.20
07.12.20
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
BioNTech SE ADR
Start price
Target price
Perf. (%)
€96.00
09.11.20
09.11.20
€105.00
2.08%
01.12.20
01.12.20
Very valuable balance sheet
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected